The DNA Synthesis Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Service (Oligonucleotide Synthesis, Gene Synthesis), By Application (Research and Development, Diagnostics, Therapeutics), By End-user (Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations).
The DNA synthesis market in 2024 addresses the demand for custom-made DNA oligonucleotides and synthetic DNA constructs used in molecular biology, genomics, synthetic biology, and biotechnology research applications. DNA synthesis involves the chemical assembly of nucleotide building blocks to create customized DNA sequences with precise lengths and sequences, enabling gene synthesis, gene editing, and functional genomics studies. Custom DNA oligos are essential reagents for PCR, DNA sequencing, gene cloning, and gene expression analysis, as well as for applications such as CRISPR-Cas9 genome editing and DNA-encoded library (DEL) screening. Market dynamics are driven by factors such as the increasing demand for synthetic biology tools and gene editing technologies, the growing adoption of DNA-based therapeutics and diagnostics, and advancements in DNA synthesis platforms and bioinformatics tools for high-throughput oligo design and assembly. Collaboration between DNA synthesis service providers, biotech companies, and academic research institutions drives innovation and market expansion in DNA synthesis, supporting diverse applications in life sciences and biomedicine.
A significant trend in the DNA Synthesis market is the increasing demand for synthetic biology applications. Synthetic biology involves the design and construction of novel biological systems or the modification of existing biological systems for various purposes, including biotechnology, pharmaceuticals, agriculture, and environmental remediation. DNA synthesis plays a crucial role in synthetic biology by enabling the generation of custom-designed DNA sequences with precise control over sequence composition, length, and functionality. This trend is driven by the growing interest in engineering biological systems for diverse applications, advancements in DNA synthesis technologies, and the expanding toolbox of synthetic biology techniques. As researchers and industries increasingly leverage synthetic biology approaches to address complex challenges and develop innovative solutions, the demand for high-quality and cost-effective DNA synthesis services is expected to grow, reshaping the landscape of biotechnology and driving market expansion in the DNA Synthesis segment.
A key driver in the DNA Synthesis market is the rapid growth in gene editing and gene therapy research. Gene editing technologies, such as CRISPR-Cas9, have revolutionized the field of molecular biology by providing precise and efficient tools for modifying DNA sequences in living organisms. Gene therapy, on the other hand, holds promise for treating genetic disorders, cancer, and other diseases by introducing therapeutic genes or correcting genetic mutations. Both gene editing and gene therapy approaches rely on DNA synthesis to produce custom-designed DNA constructs, gene vectors, and gene editing tools. This driver is fueled by the increasing investment in genomic medicine, the expansion of gene editing and gene therapy clinical trials, and the growing interest from biopharmaceutical companies in developing gene-based therapeutics. As the field of gene editing and gene therapy continues to advance towards clinical translation, the demand for DNA synthesis services to support research and therapeutic development is expected to escalate, driving market growth in the DNA Synthesis segment.
An opportunity for growth in the DNA Synthesis market lies in the development of high-throughput and scalable DNA synthesis platforms to meet the increasing demand for custom DNA constructs and gene editing tools. Traditional DNA synthesis methods, such as solid-phase synthesis and enzymatic assembly, have limitations in terms of throughput, speed, and scalability, hindering their utility for large-scale synthetic biology applications. By investing in research and development, manufacturers can innovate new DNA synthesis technologies that offer higher throughput, faster turnaround times, and lower costs per base pair. For example, microarray-based DNA synthesis platforms and microfluidic chip technologies hold promise for parallel synthesis of thousands of DNA sequences in a highly automated and cost-effective manner. Additionally, advancements in enzymatic DNA synthesis methods, such as template-independent synthesis and error correction mechanisms, could further enhance the efficiency and fidelity of DNA synthesis processes. By capitalizing on opportunities to develop high-throughput and scalable DNA synthesis platforms, manufacturers can address the growing demand for synthetic biology solutions and position themselves as leaders in the DNA Synthesis market. Embracing innovation and scalability presents a compelling avenue for market differentiation and sustained growth, offering solutions that enable breakthroughs in synthetic biology and genomic medicine.
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bioneer Corp
Eton Bioscience
Eurofins Scientific
GenScript Biotech Corp
IBA GmbH
Integrated DNA Technologies Inc
LGC Biosearch Technologies
Quintara Biosciences
Thermo Fisher Scientific Inc
Twist Bioscience
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the DNA Synthesis Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the DNA Synthesis Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 DNA Synthesis Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global DNA Synthesis Market Size Outlook, $ Million, 2021 to 2030
3.2 DNA Synthesis Market Outlook By Type, $ Million, 2021 to 2030
3.3 DNA Synthesis Market Outlook By Product, $ Million, 2021 to 2030
3.4 DNA Synthesis Market Outlook By Application, $ Million, 2021 to 2030
3.5 DNA Synthesis Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of DNA Synthesis Market Industry
4.2 Key Market Trends in DNA Synthesis Market Industry
4.3 Potential Opportunities in DNA Synthesis Market Industry
4.4 Key Challenges in DNA Synthesis Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global DNA Synthesis Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global DNA Synthesis Market Outlook By Segments
7.1 DNA Synthesis Market Outlook by Segments
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
8 North America DNA Synthesis Market Analysis And Outlook To 2030
8.1 Introduction to North America DNA Synthesis Markets in 2024
8.2 North America DNA Synthesis Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America DNA Synthesis Market size Outlook by Segments, 2021-2030
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
9 Europe DNA Synthesis Market Analysis And Outlook To 2030
9.1 Introduction to Europe DNA Synthesis Markets in 2024
9.2 Europe DNA Synthesis Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe DNA Synthesis Market Size Outlook By Segments, 2021-2030
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
10 Asia Pacific DNA Synthesis Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific DNA Synthesis Markets in 2024
10.2 Asia Pacific DNA Synthesis Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific DNA Synthesis Market size Outlook by Segments, 2021-2030
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
11 South America DNA Synthesis Market Analysis And Outlook To 2030
11.1 Introduction to South America DNA Synthesis Markets in 2024
11.2 South America DNA Synthesis Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America DNA Synthesis Market size Outlook by Segments, 2021-2030
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
12 Middle East And Africa DNA Synthesis Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa DNA Synthesis Markets in 2024
12.2 Middle East and Africa DNA Synthesis Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa DNA Synthesis Market size Outlook by Segments, 2021-2030
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bioneer Corp
Eton Bioscience
Eurofins Scientific
GenScript Biotech Corp
IBA GmbH
Integrated DNA Technologies Inc
LGC Biosearch Technologies
Quintara Biosciences
Thermo Fisher Scientific Inc
Twist Bioscience
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Service
Oligonucleotide Synthesis
-Standard Oligonucleotide Synthesis
-Custom Oligonucleotide Synthesis
Gene Synthesis
-Custom Gene Synthesis
-Gene Library Synthesis
By Application
Research and Development
Diagnostics
Therapeutics
By End-user
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global DNA Synthesis Market is one of the lucrative growth markets, poised to register a 18.4% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bioneer Corp, Eton Bioscience, Eurofins Scientific, GenScript Biotech Corp, IBA GmbH, Integrated DNA Technologies Inc, LGC Biosearch Technologies, Quintara Biosciences, Thermo Fisher Scientific Inc, Twist Bioscience
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume